79.49
price down icon1.16%   -0.93
after-market Handel nachbörslich: 79.49
loading

Finanzdaten der Lantheus Holdings Inc-Aktie (LNTH)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
5.93%
406.79
384.01 378.05 372.76 391.11
Cost Of Revenue
2.64%
165.91
161.65 137.03 135.06 142.56
Gross Profit
8.32%
240.88
222.37 241.01 237.70 248.54
Operating Expenses
8.43%
163.69
178.75 153.04 135.63 134.67
Benefits Costs and Expenses
1.53%
336.42
341.63 273.53 276.24 391.89
Costs And Expenses
1.53%
336.42
341.63 273.53 276.24 391.89
Operating Income/Loss
76.97%
77.18
43.62 87.97 102.07 113.87
Income/Loss From Continuing Operations Before Tax
66.03%
70.36
42.38 104.52 96.53 -0.783
Income Tax Expense/Benefit
11.41%
16.28
14.61 25.76 23.58 11.01
Income/Loss From Continuing Operations After Tax
94.76%
54.09
27.77 78.75 72.94 -11.79
Net Income/Loss
94.76%
54.09
27.77 78.75 72.94 -11.79
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
100.96%
-0.643
67.23 68.52 68.67 0.006
Diluted Average Shares
100.88%
-0.595
67.66 70.31 71.46 0.32
Basic Earnings Per Share
102.44%
0.83
0.41 1.15 1.06 -0.17
Diluted Earnings Per Share
97.56%
0.81
0.41 1.12 1.02 -0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$22.94
price up icon 1.15%
drug_manufacturers_specialty_generic RGC
$23.23
price down icon 3.21%
drug_manufacturers_specialty_generic RDY
$14.13
price down icon 1.53%
$129.78
price up icon 1.57%
$13.51
price down icon 2.10%
$536.12
price up icon 0.62%
Kapitalisierung:     |  Volumen (24h):